Stockreport

Athira Pharma, Inc. (ATHA) Discusses Acquisition of Rights to Lasofoxifene Phase III Program for Metastatic Breast Cancer Transcript [Seeking Alpha]

Athira Pharma, Inc.  (ATHA) 
PDF Company Participants Julie Rathbun - Head of Investor Relations Mark Litton - President, CEO & Director Javier San Martin - Chief Medical Officer Kevin Church - [Read more]